valganciclovir and Bone-Marrow-Diseases

valganciclovir has been researched along with Bone-Marrow-Diseases* in 1 studies

Other Studies

1 other study(ies) available for valganciclovir and Bone-Marrow-Diseases

Article	Year
Valganciclovir as CMV reactivation prophylaxis in patients receiving alemtuzumab for marrow failure syndromes. Annals of hematology, 2009, Volume: 88, Issue:12 Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Bone Marrow Diseases; Clinical Trials, Phase II as Topic; Ganciclovir; Humans; Immunosuppressive Agents; Recurrence; Syndrome; Valganciclovir	2009

Article

Year

Valganciclovir as CMV reactivation prophylaxis in patients receiving alemtuzumab for marrow failure syndromes.

Annals of hematology, 2009, Volume: 88, Issue:12

Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Bone Marrow Diseases; Clinical Trials, Phase II as Topic; Ganciclovir; Humans; Immunosuppressive Agents; Recurrence; Syndrome; Valganciclovir

2009